These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 32462520)
21. [Expression of glypican-3 in lung squamous cell carcinoma and adenocarcinoma and its relation with prognosis]. Li H; Deng Q; Huang L; Tang H; Cheng X Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):212-5. PubMed ID: 23443774 [TBL] [Abstract][Full Text] [Related]
22. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling. Lu C; Chen H; Shan Z; Yang L Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570 [TBL] [Abstract][Full Text] [Related]
23. The comprehensive investigation of transcription factor AP-2 alpha in lung adenocarcinoma. Liao H; Lin P Transl Cancer Res; 2020 Mar; 9(3):1547-1557. PubMed ID: 35117502 [TBL] [Abstract][Full Text] [Related]
24. Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer. Sepesi B; Nelson DB; Mitchell KG; Gibbons DL; Heymach JV; Vaporciyan AA; Swisher SG; Roszik J Ann Thorac Surg; 2018 Jun; 105(6):1621-1626. PubMed ID: 29510096 [TBL] [Abstract][Full Text] [Related]
25. Hou L; Li Y; Wang Y; Xu D; Cui H; Xu X; Cong Y; Yu C Dis Markers; 2018; 2018():4108919. PubMed ID: 30420903 [TBL] [Abstract][Full Text] [Related]
26. Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer. Sasaki H; Tanahashi M; Yukiue H; Moiriyama S; Kobayashi Y; Nakashima Y; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y Lung Cancer; 2002 Apr; 36(1):71-6. PubMed ID: 11891036 [TBL] [Abstract][Full Text] [Related]
27. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer. You Q; Guo H; Xu D Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059 [TBL] [Abstract][Full Text] [Related]
28. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma. Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059 [TBL] [Abstract][Full Text] [Related]
29. [Analysis of the correlation between the expression of WFDC2 in B cells of lung adenocarcinoma tissue and the survival rate of patients]. Zhang H; Lu J; Yang Y; Wang L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 May; 35(5):425-433. PubMed ID: 31223112 [TBL] [Abstract][Full Text] [Related]
30. Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer. Huang C; Liu J; Xiong B; Yonemura Y; Yang X Gene; 2019 Feb; 685():202-210. PubMed ID: 30415009 [TBL] [Abstract][Full Text] [Related]
31. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer. Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287 [TBL] [Abstract][Full Text] [Related]
32. Human complement factor H is a novel diagnostic marker for lung adenocarcinoma. Cui T; Chen Y; Knösel T; Yang L; Zöller K; Galler K; Berndt A; Mihlan M; Zipfel PF; Petersen I Int J Oncol; 2011 Jul; 39(1):161-8. PubMed ID: 21503575 [TBL] [Abstract][Full Text] [Related]
33. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma. Cui Y; Cui CA; Yang ZT; Ni WD; Jin Y; Xuan YH Exp Mol Pathol; 2017 Apr; 102(2):347-353. PubMed ID: 28286162 [TBL] [Abstract][Full Text] [Related]
34. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Corson TW; Zhu CQ; Lau SK; Shepherd FA; Tsao MS; Gallie BL Clin Cancer Res; 2007 Jun; 13(11):3229-34. PubMed ID: 17545527 [TBL] [Abstract][Full Text] [Related]
35. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis. Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459 [TBL] [Abstract][Full Text] [Related]
36. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features. Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507 [TBL] [Abstract][Full Text] [Related]
37. AKR1B10 is associated with smoking and smoking-related non-small-cell lung cancer. Kang MW; Lee ES; Yoon SY; Jo J; Lee J; Kim HK; Choi YS; Kim K; Shim YM; Kim J; Kim H J Int Med Res; 2011; 39(1):78-85. PubMed ID: 21672310 [TBL] [Abstract][Full Text] [Related]
38. Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1). Shimoji M; Shimizu S; Sato K; Suda K; Kobayashi Y; Tomizawa K; Takemoto T; Mitsudomi T Lung Cancer; 2016 Aug; 98():69-75. PubMed ID: 27393509 [TBL] [Abstract][Full Text] [Related]
39. MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer. Ko JL; Cheng YW; Chang SL; Su JM; Chen CY; Lee H Int J Cancer; 2000 May; 89(3):265-70. PubMed ID: 10861503 [TBL] [Abstract][Full Text] [Related]
40. Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas. Seki Y; Yoshida Y; Ishimine H; Shinozaki-Ushiku A; Ito Y; Sumitomo K; Nakajima J; Fukayama M; Michiue T; Asashima M; Kurisaki A Biochem Biophys Res Commun; 2014 Jan; 443(4):1141-7. PubMed ID: 24380866 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]